Skip to main content
. 2023 Aug 28;3(8):1672–1677. doi: 10.1158/2767-9764.CRC-23-0230

FIGURE 2.

FIGURE 2

Maximum CA 19-9 responses in the expansion cohort. Figure shows the CA 19-9 percent change from baseline according to response of progressive disease (PD), SD, PR, CR, or not evaluable (NE).